|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―May―23 |
A Scoping Review of Bacterial Resistance Among Inpatients Amidst the COVID-19 Pandemic |
Noora Reffat, Rebecca J Schwei, Meggie Griffin, Aurora Pop-Vicas, Lucas T Schulz, Michael S Pulia |
2 |
[GO] |
2024―May―07 |
Clinical characteristics and risk factors for bacterial co-infections in COVID-19 patients: A retrospective study |
Yichuan Gan, Guowen Zhang, Hengbiao Sun, Xiaoming Lyu |
3 |
[GO] |
2024―Mar―27 |
When it rains it pours: an increased prevalence of intestinal carriage of vancomycin-resistant Enterococcus faecium related to higher use of oral vancomycin in a tertiary care Hungarian clinical center during the years of the COVID-19 pandemic |
László Orosz |
4 |
[GO] |
2024―Mar―07 |
Changes in antimicrobial resistance of Escherichia coli isolated from community associated urinary tract infection before and during the COVID-19 pandemic in India |
Shwetha Venugopal, Sneha Chunchanur, Rajashree Panigrahy, Vibhor Tak, Manish Yadav, Akanksha Chauhan, et al. (+9) Himabindhu KS, Jayapriya R, Swati Pundir, Satyendra Bhatt, Birasen Behera, Sumanth M, Ambica R, Susmita Chaudhuri, Sarita Mohapatra |
5 |
[GO] |
2024―Jan―26 |
Genomic surveillance of carbapenem-resistant Klebsiella pneumoniae reveals a prolonged outbreak of extensively drug-resistant ST147 NDM-1 during the COVID-19 pandemic in the Apulia region (Southern Italy) |
Daniela Loconsole, Anna Sallustio, Davide Sacco, Marilina Santantonio, Daniele Casulli, Domenico Gatti, et al. (+6) Marisa Accogli, Antonio Parisi, Riccardo Zagaria, Vito Colella, Francesca Centrone, Maria Chironna |
6 |
[GO] |
2024―Jan―03 |
An Evaluation of the Five Rights Antibiotic Safety Before and During COVID-19 at an NHS Foundation Trust in the United Kingdom |
Rasha Abdelsalam Elshenawy, Nkiruka Umaru, Zoe Aslanpour |
7 |
[GO] |
2023―Aug―22 |
Co-infection in COVID-19 patients performed microbiology detection: discovering multi-drug resistant microorganisms increased during the COVID-19 pandemic in Shanghai, China |
Xin Jin, Liyan Zeng, Lijun Zhang, Zhaoqin Zhu |
8 |
[GO] |
2023―Apr―13 |
Corrigendum to “Antibiotic expectation, behaviour, and receipt among patients presenting to emergency departments with uncomplicated upper respiratory tract infection during the COVID-19 pandemic” [Journal of Global Antimicrobial Resistance 33 (2023) 89-96] |
Zhilian Huang, Win Sen Kuan, Hann Yee Tan, Eillyne Seow, Ling Tiah, Li Lee Peng, et al. (+2) Yanyi Weng, Angela Chow |
9 |
[GO] |
2023―Mar―10 |
Antibiotic expectation, behaviour, and receipt among patients presenting to emergency departments with uncomplicated upper respiratory tract infection during the COVID-19 pandemic |
Zhilian Huang, Win Sen Kuan, Hann Yee Tan, Eillyne Seow, Ling Tiah, Li Lee Peng, et al. (+2) Yanyi Weng, Angela Chow |
10 |
[GO] |
2022―Dec―23 |
Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial |
Florian Kurth, Elisa T. Helbig, Lena J. Lippert, Charlotte Thibeault, Gianluca Barbone, Marius A. Eckart, et al. (+12) Martin Kluge, Tobias Puengel, Münevver Demir, Robert Röhle, Theresa Keller, Christoph Ruwwe-Glösenkamp, Martin Witzenrath, Norbert Suttorp, Christof von Kalle, Leif E. Sander, Christoph Jochum, Frank Tacke |
11 |
[GO] |
2022―Dec―19 |
61: SECONDARY INFECTION DURING THE THIRDWAVE OF COVID-19 IN A HOSPITAL IN KATHMANDU |
S.K. Mishra Baishnab |
12 |
[GO] |
2022―Dec―19 |
WS1.3: DETERMINANTS OF ANTIBIOTIC EXPECTATION AND RECEIPT AMONG PATIENTS PRESENTING TO EMERGENCY DEPARTMENTS WITH UPPER RESPIRATORY TRACT INFECTION DURING THE COVID-19 PANDEMIC |
Zhilian Huang, Angela Chow |
13 |
[GO] |
2022―Dec―19 |
WS1.2: USE OF ANTIBIOTICS IN COVID-19 PATIENTS AND ANTIBACTERIAL RESISTANCE PATTERN- A COUNTRYWIDE PICTURE |
Shrebash Paul, Tabiha Binte Hannan, T.M. Al-Amin, Md. Mohiuddin Khan, Binayak Bhattacharjee, Md. Zainal Abedin, et al. (+6) Pritish Tarafder, Md. Abul Kalam Azad, Shohael Mahmud Arafat, Md. Rafiqul Alam, Md. Mujibur Rahman, Fazle Rabbi Chowdhury |
14 |
[GO] |
2022―Dec―19 |
63: A MICROBIOLOGICAL RETROSPECTIVE REVIEW OF BLOOD STREAM INFECTIONS IN COVID-19 PATIENTS FROM A TERTIARY CARE CENTER IN LEBANON |
S. Nahhal, N. Zahreddine, J. Tannous, N. Haddad, J. Zakhour, A. Shmoury, et al. (+3) T. Sawma, N. Rizk, S.S Kanj |
15 |
[GO] |
2022―Dec―19 |
64: BACTERIAL RESPIRATORY INFECTIONS IN PATIENTS WITH COVID-19: A RETROSPECTIVE STUDY FROM A TERTIARY CARE CENTER IN LEBANON |
A. Shmoury, T. Sawma, S.F. Haddad, N. Zahreddine, J. Tannous, J. Zakhour, et al. (+2) N. Rizk, S.S Kanj |
16 |
[GO] |
2022―Dec―19 |
54: THE IMPACT OF THE CORONAVIRUS DISEASE PANDEMIC ON RESPIRATORY-RELATED INFECTIONS IN JAPAN |
D. Kitagawa, T. Kitano, M. Furumori, S. Suzuki, Y. Shintani, A. Nishiyama, et al. (+9) T. Kasamatsu, N. Shiraishi, Y. Suzuki, A. Nakano, R. Nakano, H. Yano, K. Maeda, S. Yoshida, F. Nakamura |
17 |
[GO] |
2022―Dec―19 |
58: SARS-COV-2 ANTIBODY CHARACTERISTICS OF SALIVA FROM VACCINATED INDIVIDUALS |
K. Ota, F. Mitsumoto-Kaseida, K. Sakamoto, K. Kosai, H. Hasegawa, K. Yamamoto, et al. (+4) K. Izumikawa, H. Mukae, S. Kohno, K. Yanagihara |
18 |
[GO] |
2022―Dec―19 |
69: COMPARING THE OUTCOMES OF GIVING TOCILIZUMAB THEN HEMOPERFUSION, HEMOPERFUSION THEN TOCILIZUMAB, AND NO INTERVENTION IN CRITICAL SARS-COV-2 PNEUMONIA PATIENTS IN MAKATI MEDICAL CENTER |
M.V.R. Macatangay, J.A. Buensalido |
19 |
[GO] |
2022―Dec―01 |
Effect of Farnesyltransferase Inhibitors on SARS-CoV-2 |
Lea Weber, Lena Mautner, Mona Hoyos, Anja Ehrhardt, Armin Baiker, Hagen Sjard Bachmann |
20 |
[GO] |
2022―Nov―08 |
Replacement of KPC-producing pandemic lineages and dissemination of plasmids associated to antimicrobial resistance determinants during inpatient´s hospitalization |
Verónica E. Álvarez, Natalia García Allende, Mariana G. Massó, María Piekar, Josefina Campos, Barbara Fox, et al. (+4) Anahí S. Gambino, Liliana Fernández-Canigia, María P. Quiroga, Daniela Centrón |
21 |
[GO] |
2022―Oct―05 |
In vitro activity of ceftazidime/avibactam against carbapenem-non-susceptible Klebsiella penumoniae isolates collected during SARS-CoV-2 pandemic: a Southern Italy, multi-center, surveillance study |
Gianfranco La Bella, Teresa Lopizzo, Laura Lupo, Rosa Angarano, Anna Curci, Barbara Manti, et al. (+4) Giovanna La Salandra, Adriana Mosca, Rosella De Nittis, Fabio Arena |
22 |
[GO] |
2022―Jun―13 |
Overuse of empirical antibiotics in a Covid-19 intensive care unit led to the spread of carbapenem-resistant Gram-negative bacteria in a teaching hospital |
Daniela Dambroso-Altafini, Silvia Maria dos Santos Saalfeld, Monica de Souza Ferreira de Mattos, Hilton Vizzi Martinez, Danielle Rosani Shinohara, Mirian Nicéa Zarpellon, et al. (+2) Bruno Buranello Costa, Maria Cristina Bronharo Tognim |
23 |
[GO] |
2022―Feb―25 |
Preexisting conditions among the SARS-CoV2 deaths during the SARS-CoV2 B.1.617.2 (Delta variant) outbreak in the United Kingdom |
Venkata R. Emani, Raghunath Reddy, Kartik K. Goswami, Abirath S. Nakka, Shaila R. Emani, Nikhila K. Reddy, et al. (+3) Kailash R. Maddula, Dheeraj Nandanoor, Sanjeev Goswami |
24 |
[GO] |
2022―Jan―14 |
In vitro evaluation of virucidal activity of disodium citrate perhydrate (2SCP) disinfectant against SARS-CoV-2 virus |
Géraldine Dessilly, Anne-thérèse Pâques, Anne-thérèse Vandenbroucke, Pierre Hazée, Alain Gaume, Katia Gindro, et al. (+3) Sylvain Schnée, Frédéric Lakaye, Benoît Kabamba-Mukadi |
25 |
[GO] |
2021―Nov―12 |
Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy |
Briony Adams, Alec Beaney |
26 |
[GO] |
2021―Nov―04 |
COVID-19 disease severity is linked to host immunity as well as lung and gut dysbiosis: a narrative review |
Nobuhiro Asai, Hiroshige Mikamo |
27 |
[GO] |
2021―Oct―28 |
Repatriation of patient with COVID-19 contributed to the importation of an emerging carbapenemase producer |
Aline I. Moser, Edgar I. Campos-Madueno, Parham Sendi, Vincent Perreten, Peter M. Keller, Alban Ramette, Andrea Endimiani |
28 |
[GO] |
2021―Sep―22 |
Successful prolonged cefiderocol treatment of a chronic left pleural empyema caused by Pseudomonas aeruginosa in a patient affected by COVID-19: a case report |
Luca Borghesi, Valentina Viaggi, Marco Franzetti, Matteo Montoli, Carola Mauri, Giovanni Moioli, et al. (+3) Mauro Roberto Benvenuti, Stefania Piconi, Francesco Luzzaro |
29 |
[GO] |
2021―Sep―04 |
Shortage in Appropriate Diagnostics of Antimicrobial Resistance in Lebanese Clinical Settings: A Crisis Amplified by COVID-19 and Economic Collapse |
Marwan Osman, Dalal Kasir, Issmat I. Kassem, Monzer Hamze |
30 |
[GO] |
2021―Jul―15 |
Loss of Function Mutations in the IFNAR2 in COVID-19 Severe Infection Susceptibility |
Sandra P. Smieszek, Mihael H. Polymeropoulos |
31 |
[GO] |
2021―Jul―07 |
Vaccine or Monoclonal therapy: which is winning weapon against COVID-19? |
Lorenzo Lo Muzio, Maria Eleonora Bizzoca |
32 |
[GO] |
2021―Jun―09 |
What prompts clinicians to start antibiotic treatment in COVID-19 patients? An Italian web-survey helps us understand where the doubts lie |
Marta Colaneri, Pietro Valsecchi, Marco Vecchia, Alessandro Di Filippo, Valentina Zuccaro, Elena Seminari, et al. (+6) Paolo Sacchi, Laura Maiocchi, Massimiliano Fabbiani, Alessandra Ricciardi, Alba Muzzi, Raffaele Bruno |
33 |
[GO] |
2021―May―27 |
Epigallocatechin-3-gallate (EGCG): a potential molecule for the development of therapeutics against emerging SARS-CoV-1, MERS-CoV and SARS-CoV-2 coronaviruses |
Jeswin Joseph, T. Karthika, V.R. Akshay Das, V. Stalin Raj |
34 |
[GO] |
2021―Mar―01 |
AMR research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic |
Jesús Rodríguez-Baño, Gian Maria Rossolini, Constance Schultsz, Evelina Tacconelli, Srinivas Murthy, Norio Ohmagari, et al. (+17) Alison Holmes, Till Bachmann, Herman Goossens, Rafael Canton, Adam P. Roberts, Birgitta Henriques-Normark, Cornelius J. Clancy, Benedikt Huttner, Patriq Fagerstedt, Shawon Lahiri, Charu Kaushic, Steven J. Hoffman, Margo Warren, Ghada Zoubiane, Sabiha Essack, Ramanan Laxminarayan, Laura Plant |
35 |
[GO] |
2021―Mar―01 |
Genomic Data Reveals the Emergence of IncQ1 Small Plasmid Carrying blaKPC-2 in Escherichia coli of the Pandemic Sequence Type 648 |
Bruna Fuga, Louise Cerdeira, Quézia Moura, Herrison Fontana, Danny Fuentes-Castillo, Albalúcia C. Carvalho, Nilton Lincopan |
36 |
[GO] |
2021―Jan―18 |
Hydroxychloroquine serum concentrations in non-critical care patients infected with SARS-CoV-2 |
Alasdair MacGowan, Fergus Hamilton, Mark Bayliss, Liam Read, Marie Attwood, Alan Noel, et al. (+4) Sally Grier, Anna Morley, David Arnold, Nicholas Maskell |
37 |
[GO] |
2020―Dec―29 |
Antiviral activity of interferon-based combination therapy in critically ill patients with Covid-19: preliminary observations |
Paolo Gaibani, Tommaso Tonetti, Michele Bartoletti, Maria Carla Re, PierLuigi Viale, V. Marco Ranieri |
38 |
[GO] |
2020―Dec―25 |
Treatment of a case with COVID-19 administering intravenous immunoglobulin |
Mustafa Çolak, Serdar Kalemci, Aydın Sarıhan |
39 |
[GO] |
2020―Dec―08 |
A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19) |
Sock Hoon Tan, Tat Ming Ng, Hui Lin Tay, Min Yi Yap, Shi Thong Heng, Audrey Yong Xin Loo, et al. (+2) Christine B. Teng, Tau Hong Lee |
40 |
[GO] |
2020―Dec―08 |
Remdesivir for the treatment of coronavirus COVID-19: a meta-analysis of randomised controlled trials |
Yuki Enoki, Yuki Igarashi, Yuki Watabe, Kyoka Honma, Yuto Suzuki, Yukitaka Hayashi, et al. (+3) Kana Hiraoka, Kazuaki Taguchi, Kazuaki Matsumoto |
41 |
[GO] |
2020―Nov―23 |
Cytokine storm of a different flavor: the different cytokine signature of SARS-CoV2 the cause of COVID-19 from the original SARS outbreak |
Daniel O. Griffin, Alexandra Jensen, Mushmoom Khan, Jessica Chin, Kelly Chin, Jennifer Saad, et al. (+3) Ryan Parnell, Christopher Awwad, Darshan Patel |
42 |
[GO] |
2020―Nov―23 |
Carbapenem resistant Klebsiella pneumoniae in ICU-admitted COVID-19 Patients: Keep an eye on the ball |
G. Montrucchio, S. Corcione, G. Sales, A. Curtoni, F.G. De Rosa, L. Brazzi |
43 |
[GO] |
2020―Oct―29 |
INCIDENCE OF BACTERIAL AND FUNGAL BLOODSTREAM INFECTIONS IN COVID-19 PATIENTS IN INTENSIVE CARE: AN ALARMING “COLLATERAL EFFECT” |
Maria Adriana Cataldo, Nardi Tetaj, Marina Selleri, Luisa Marchioni, Alessandro Capone, Emanuela Caraffa, et al. (+2) Antonino Di Caro, Nicola Petrosillo |
44 |
[GO] |
2020―Oct―17 |
Ototoxicity prevention during the SARS-CoV-2 (Covid-19) emergency |
Andrea Ciorba, Piotr Henryk Skarżyński, Stefano Pelucchi, Stavros Hatzopoulos |
45 |
[GO] |
2020―Oct―13 |
A Possible Application of High Dose Vitamin C in the Prevention and Therapy for Coronavirus Infections |
Ba X. Hoang, D. Graeme Shaw, William Fang, Bo Han |
46 |
[GO] |
2020―Aug―20 |
A comprehensive strategy for the early treatment of COVID-19 with azithromycin/hydroxychloroquine and/or corticosteroids: results of a retrospective observational study in the French overseas department of Reunion Island |
Arthur Dubernet, Kevin Larsen, Laurie Masse, Jérôme Allyn, Emilie Foch, Lea Bruneau, et al. (+14) Adrien Maillot, Marie Lagrange-Xelot, Vincent Thomas, Marie-Christine Jaffar-Bandjee, Loraine Gauzere, Loic Raffray, Karine Borsu, Servane Dibernardo, Stéphane Renaud, Michel André, Diane Moreau, Julien Jabot, Nathalie Coolen-Allou, Nicolas Allou |
47 |
[GO] |
2020―Aug―15 |
Neutrophil-to-lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients |
Shaghayegh Haghjooy Javanmard, Golnaz Vaseghi, Amir Reza Manteghi Nezhad, Maryam Nasirian |
48 |
[GO] |
2020―Aug―15 |
Usefulness of brochoalveolar lavage in suspect covid-19 repeatedly negative swab test and interstitial lung disease |
Jacopo Vannucci, Franco Ruberto, Daniele Diso, Gioacchino Galardo, Claudio M. Mastroianni, Giammarco Raponi, et al. (+6) Massimiliano Bassi, Giancarlo Ceccarelli, Massimo Mancone, Guido Antonelli, Federico Venuta, Francesco Pugliese |
49 |
[GO] |
2020―Aug―08 |
Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-COV-2 infection? |
Sudhir Mehta, Sudhir Bhandari, Shaurya Mehta |
50 |
[GO] |
2020―Aug―05 |
Hydroxychloroquine use in Hospitalized Patients with COVID-19: An observational matched cohort study |
Markos Kalligeros, Fadi Shehadeh, Eleftheria Atalla, Evangelia K. Mylona, Su Aung, Aakriti Pandita, et al. (+7) Jerry Larkin, Martha Sanchez, Francine Touzard-Romo, Amy Brotherton, Rajeev Shah, Cheston B. Cunha, Eleftherios Mylonakis |
51 |
[GO] |
2020―Jul―25 |
Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care |
Lesley Heesom, Lucas Rehnberg, Myra Nasim-Mohi, Alexander I.R. Jackson, Michael Celinski, Ahilanadan Dushianthan, et al. (+3) Paul Cook, William Rivinberg, Kordo Saeed |
52 |
[GO] |
2020―Jul―16 |
Could Bordetella pertussis vaccine protect against coronavirus COVID-19? |
Usama M. Alkholy, Mohamed E Salama, Hagar Mahmoud, Ahmed Taher, Khaled M. Elsayes |
53 |
[GO] |
2020―Jul―11 |
Perceived Challenges of COVID-19 Infection Prevention and Control Preparedness: A Multinational Survey |
Ermira Tartari, Joost Hopman, Benedetta Allegranzi, Bin Gao, Andreas Widmer, Vincent Chi-Chung Cheng, et al. (+4) Shuk Ching Wong, Kalisvar Marimuthu, Folasade Ogunsola, Andreas Voss |
54 |
[GO] |
2020―Jul―02 |
SARS-CoV-2 positivity in rectal swabs implication for possible transmission |
Federica Novazzi, Irene Cassaniti, Antonio Piralla, Antonio Di Sabatino, Raffaele Bruno, Fausto Baldanti |
55 |
[GO] |
2020―Jul―01 |
Azithromycin and SARS-CoV-2 infection: where we are now and where we are going |
Luis Gabriel Parra-Lara, Juan José Martínez-Arboleda, Fernando Rosso |
56 |
[GO] |
2020―Jun―12 |
The lurking scourge of multidrug resistant Candida auris in times of COVID-19 pandemic |
Anuradha Chowdhary, Amit Sharma |
57 |
[GO] |
2020―May―29 |
Vitamin D deficiency and COVID-19 pandemic |
Patrick Zemb, Peter Bergman, Carlos A. Camargo, Etienne Cavalier, Catherine Cormier, Marie Courbebaisse, et al. (+7) Bruce Hollis, Salvatore Minisola, Stefan Pilz, Pawel Pludowski, François Schmitt, Mihnea Zdrenghea, Jean-Claude Souberbielle |
58 |
[GO] |
2020―Apr―27 |
Continues Renal Replacement Therapy (CRRT) With Disposable Hemoperfusion Cartridge: A Promising Option for Severe COVID-19 |
Farzaneh Dastan, Ali Saffaei, Seyed Mehdi Mortazavi, Hamidreza Jamaati, Nadia Adnani, Sasan Samiee Roudi, et al. (+3) Arda Kiani, Atefeh Abedini, Seyed MohammadReza Hashemian |
59 |
[GO] |
2020―Mar―07 |
2019-novel coronavirus outbreak: A new challenge |
Tommaso Lupia, Silvia Scabini, Simone Mornese Pinna, Giovanni Di Perri, Francesco Giuseppe De Rosa, Silvia Corcione |